Antiretroviral Therapy
Nevirapine tolerance induction safe, effective
Published in AIDS Weekly, July 1st, 2002
"The most frequent side-effects due to nevirapine (Viramune), the first non-nucleoside HIV reverse transcriptase inhibitor introduced for clinical use, are cutaneous hypersensitivity reactions," explained Djamel Messaad and colleagues at Arnaud de Villeneuve Hospital, Montpellier University Hospital and Gui de Chauliac Hospital in Montpellier.
Tolerance can be safely, rapidly, and durably induced in patients with limited treatment options who experience such reactions, the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2002-07-01)
More Articles from AIDS Weekly
- AIDS and HIV Pathogenesis
Viral gp120 not needed for infection - AIDS and HIV Therapy
Cost-effectiveness of African intervention programs scrutinized - AIDS and HIV Therapy
Opioid-induced immune suppression can be prevented - IDS Therapy
Hebrew University student develops method to check if AIDS patients developed resistance to drugs - AIDS and HIV Pathogenesis
Viral Th2 cytokine expression can enhance infection - Advocacy
HIV/AIDS experts call for end of economic sanctions against Haiti - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
